drugset / Trial / NCT02491723

Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa

NCT02491723

NaSingle-groupOpen-labelTreatment

Summary

It is acknowledged that IL-18, as a product of the inflammasome, is involved in host defence against viral and bacterial stimuli by modulating the immune response. The aim of this study was to determine IL-18 levels in serum of patients with Bronchiectasis and to investigate whether macrolide attenuate its levels.

Timeline

Start
2014-01
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 500 mg

Indications